FIGURE 2 - uploaded by Nadine Dexter
Content may be subject to copyright.
Nicholas Senn (1844 –1908). A childhood immi- grant from Switzerland, Senn graduated from Chicago Medical School in 1868. After working at Cook County Hospital for several years, he journeyed to Munich for postgraduate studies under Professor Johann von Nussbaum. In 1878, he joined the faculty at Rush Medical College as Professor of Surgery. While at Rush, he carried out numerous animal experiments involving surgery of the pancreas, thereby providing the investigative basis for future generations of surgical scientists. He left his position in 1898 to become Chief Sur- geon of the Army Medical Corps in Cuba during the Span- ish-American War.
Source publication
Throughout much of history, surgery of the pancreas was restricted to drainage of abscesses and treatment of traumatic wounds. At the turn of the 20th century under the impetus of anesthesia, such surgical stalwarts as Mayo Robson, Mickulicz, and Moynihan began to deploy laparotomy and gauze drainage in an effort to salvage patients afflicted with...
Contexts in source publication
Context 1
... 1886, Nikolas Senn ( Fig. 2) published extensive animal experiments describing surgery of the gland. 12 Furthermore, he offered his own clinical classification of acute pancreatitis, embod- ying gangrene, abscess, and hemorrhage of the gland, 3 years prior to the classification proposed by Fitz. Senn wrote that "One of the terminations of acute inflammation of ...
Context 2
... and continuing well into the Middle Ages, such diverse diseases as pancreatic malignancy, chronic pancreatitis, and various forms of acute pancreatitis and its complications were all lumped together under the heterogeneous classification of “scirrhi” (hard) conditions. The longevity of ancient medical dogma was considerably abetted by the edict from the medieval Catholic Church prohibiting human dissection, as well as to the unwillingness of scholars to chal- lenge the classic opinions of Galen. As a result, clinicopathologic differentiation among human diseases did not begin to emerge until late in the fifteenth century, when human postmortem dissection began to be practiced in Bologna, Padua, and other European university centers. The first recorded description of necrotizing pancreatitis is apparently that of Nikolaus Tulp, a Dutch physician and anatomist, who in 1652 performed a postmortem examination upon a young man afflicted by an apocalyptic attack of abdominal pain that proved to be fatal after 5 days. 2 At autopsy, the gland was found to be enlarged, purulent, and “rotten.” No explanation was offered for the observed changes in the pancreas. Similar anatomic studies were infrequent, however, and acute inflammation of the pancreas continued to be considered a rare condition. Failure to recognize acute pancreatitis as a separate disease entity was partly because symptoms were often attributed to other, more well-known diseases, and partly due to the relatively small number of postmortem examinations being performed. It was not until 1842 that acute pancreatitis was proposed as a distinct clinical entity. Heinrich Claessen, a physician in Cologne, collected a series of 6 fatal cases of severe acute pancreatitis from the literature of the times. 3 He noted a common clinical and pathologic presentation among these cases, and suggested that this commonality in presentation might be useful for diagnosis. Over the next 50 years, increasing numbers of autopsy-based studies of necrotizing pancreatitis by such eminent pathologists as Rokitansky, Klebs, Friedrich, and Chiari, confirmed Claessen’s initial clinical observations. 4 –7 Theodor Klebs, a student of Virchow, and professor of pathologic anatomy and bacteriology in Berne, proposed that hemorrhagic pancreatitis was related to necrotizing pancreatitis, and to subsequent suppuration of the gland. Moreover, he first postulated that the destruction of the pancreas was caused by the well-known “corroding qualities” of the gland secre- tions. Nikolaus Friedreich, also a student of Virchow, who later rose to become professor of pathology in Wurzberg, suggested a postmortem classification of acute pancreatitis in 1882 consisting of hemorrhage, gangrene, and abscess formation. His classification was admittedly restricted as it was based upon but 4 cases, only one of which was personally observed by the author. A year later, Hans Chiari, professor of pathology in Prague, published his findings concerning the pathophysiology of acute pancreatitis, attributing the destruction of the gland to the “autodigestive” properties of pancreatic ferments. In 1889, Reginald Fitz, the Shattuck Professor of Pathoanatomy at Harvard, former pupil of Rokitansky, Virchow, and Billroth, and already well known for his clinicopathologic description of appendicitis, published a Hunterian Lecture in which a pathology-based classification system for acute pancreatitis was proposed (Fig. 1). As a result of Fitz’ classification system, clinicians were enabled to make an antemortem diagnosis of acute pancreatitis. 8 Although this autopsy-based classification system, including hemorrhagic, gangrenous, and suppurative forms, was superficially similar to the earlier one proposed by Friedrich, Fitz’s classification system involved a melding of clinical symptomatology and pathologic findings derived from a painstaking collective review of prior cases in the literature, with a few cases added from the Boston area. Even though Fitz noted that the hemorrhagic, suppurative, and gangrenous forms of acute pancreatitis were often combined with disseminated fat necrosis, he was seemingly unaware that fat necrosis was a different manifestation of the same disease process. During this period of awakening interest in the pancreas, surgeons were not idle. According to Hollender, 9 Wandeleben had incised and drained a pancreatic abscess as early as 1845, although the result of this effort is unknown. In 1882, Rosenbach marsupial- ized an abscess of the pancreas. Unfortunately, the patient died, reportedly in “schock” 6 hours after surgery. 10 Hirschberg performed an exploratory laparotomy in 1887 in an obese male who had suffered a “collapse” 4 days after the onset of hemorrhagic pancreatitis, but within 5 hours after exploration, his patient also expired. 11 These initially unsuccessful forays into the surgical management of necrotizing pancreatitis did not deter surgical interest. In 1886, Nikolas Senn (Fig. 2) published extensive animal experiments describing surgery of the gland. 12 Furthermore, he offered his own clinical classification of acute pancreatitis, embod- ying gangrene, abscess, and hemorrhage of the gland, 3 years prior to the classification proposed by Fitz. Senn wrote that “One of the terminations of acute inflammation of the pancreas is gangrene. It would seem plausible that timely removal of the necrosed organ by surgical interference would add to the chances of recovery. Conse- quently, we shall add gangrene as one of the diseases of the pancreas which should be treated by operative measures” (p 175). Of note, however, although Senn remained a staunch advocate for surgical intervention in acute pancreatitis for his entire career, there does not seem to be any record of whether he actually performed such operations. Nevertheless, his influence on the so-called “Chicago School of Surgery” was profound and long-lasting. Senn’s application of the scientific method to a clinical problem ignited the interest of many other surgeons to employ surgical techniques in human acute pancreatitis. Many students of surgical history are aware that 3 years later in 1889, Fitz was adamant that surgery would not benefit patients with acute pancreatitis, and that fatalities could not be prevented by operative “meddling.” Less well known, however, is the observation that Fitz appeared to modify his antisurgical stance in a subsequent publication in 1903, in which he allowed that some surgical successes had been reported in these desperately ill patients. 13 The initial operative success in the management of necrotizing pancreatitis was reported by Werner Koerte (Fig. 3) in 1894. He described the successful drainage of a large pancreatic abscess via a left flank incision in a 48-year-old obese woman 1 month after the onset of severe pancreatitis. 14 Iodoform gauze-wrapped drains were placed into the retroperitoneum, and postoperative management consisted of repeated changes of the gauze. After wound discharge of a considerable amount of necrotic pancreas and fatty tissue, and the formation of a pancreatic fistula, the patient was discharged completely healed 5 months later. Unfortunately, 2 other cases of postnecrotic abscess in his series that were treated similarly expired due to recurrent infection. Koerte advocated delayed exploration of pancreatic infections: “In the acute stage, surgical treatment is not recommended, wherein patients have the propensity for cardiovas- cular collapse. If pancreatic apoplexy occurs, surgical treatment cannot help. Later, when we can prove that a purulent collection is arising from the gland, surgery is indicated” (p 739). These thoughts antedate the contemporary approach to surgery for necrotizing pancreatitis by more than 90 years. One year later, in 1895, Thayer from the Johns Hopkins Hospital reported a similar case of necrotizing pancreatitis with secondary infection that had been operated upon by JMT Finney, using debridement and closed drainage. The patient recovered and was discharged 4 months after the initial exploration. 15 Six years later, from the same institution, Opie generalized from a single autopsy case that hemorrhagic pancreatitis resulted from unremitting obstruction of the pancreatic and bile ducts by biliary calculi. 16 Given these initial successes, surgeons flocked to the banner of operative intervention in acute pancreatitis. 17–19 At the turn of the twentieth century, such surgical stalwarts as Mayo Robson and Mickulicz also reported successful surgical interventions in necrotizing pancreatitis. In the second of 3 scholarly Hunterian Lectures given before the Royal College of Surgeons of England in 1904, Mayo Robson (Fig. 4) described 2 survivors in 4 early operations for necrotizing pancreatitis, and 5 survivors in 6 operations for pancreatic abscess. 20 He noted that in contrast to previous beliefs “... inflammatory afflictions of the pancreas are very much more com- mon than is generally supposed” (p 846). Johann von Mikulicz, Professor of Surgery in Breslau, and also a former student of Billroth, advocated early exploration in necrotizing pancreatitis, but favored pancreatic marsupialization by “pancreatostomy,” rather than by gauze drainage. 21 In rapid succession, other surgeons reported successful procedures in patients with necrotizing pancreatitis and its complications. Woolsey, a Professor of Surgery at Columbia, described 3 cases of successful early exploration in necrotizing pancreatitis employing debridement and gauze drainage. 22 Similarly successful anecdotal experiences with this approach were reported by Bunge 23 and Villar. 24 The favored technique consisted of surgical intervention early in the course of acute hemorrhagic/necrotizing pancreatitis, incisions into the pancreatic “capsule,” and gauze drainage of the peripancreatic region. In contrast, delayed intervention for pancreatic abscesses was preferred, employing ...
Citations
... Medical advancements have resulted in significant progress in the endoscopic treatment of iNP. historically, prior to the twentieth century, conservative management of iNP was more prevalent than surgical intervention [6,30]. however, approximately ten years ago, surgical treatment in the form of open necrosectomy gained widespread acceptance as a viable approach for severe pancreatitis [31,32]. in the twenty-first century, with the advent of Mis, there is mounting evidence indicating that minimally invasive approaches are preferable to open surgery [33][34][35][36][37]. ...
Background/Aims
Acute pancreatitis is a common condition of the digestive system, but sometimes it develops into severe cases. In about 10–20% of patients, necrosis of the pancreas or its periphery occurs. Although most have aseptic necrosis, 30% of cases will develop infectious necrotizing pancreatitis. Infected necrotizing pancreatitis (INP) requires a critical treatment approach. Minimally invasive surgical approach (MIS) and endoscopy are the management methods. This meta-analysis compares the outcomes of MIS and endoscopic treatments.
Methods
We searched a medical database until December 2022 to compare the results of endoscopic and MIS procedures for INP. We selected eligible randomized controlled trials (RCTs) that reported treatment complications for the meta-analysis.
Results
Five RCTs comparing a total of 284 patients were included in the meta-analysis. Among them, 139 patients underwent MIS, while 145 underwent endoscopic procedures. The results showed significant differences (p < 0.05) in the risk ratios (RRs) for major complications (RR: 0.69, 95% confidence interval (CI): 0.49–0.97), new onset of organ failure (RR: 0.29, 95% CI: 0.11–0.82), surgical site infection (RR: 0.26, 95% CI: 0.07–0.92), fistula or perforation (RR: 0.27, 95% CI: 0.12–0.64), and pancreatic fistula (RR: 0.14, 95% CI: 0.05–0.45). The hospital stay was significantly shorter for the endoscopic group compared to the MIS group, with a mean difference of 6.74 days (95% CI: −12.94 to −0.54). There were no significant differences (p > 0.05) in the RR for death, bleeding, incisional hernia, percutaneous drainage, pancreatic endocrine deficiency, pancreatic exocrine deficiency, or the need for enzyme use.
Conclusions
Endoscopic management of INP performs better compared to surgical treatment due to its lower complication rate and higher patient life quality.
... The management of pseudocysts and necrotic collections in severe AP is matter of contention in the surgical literature since the 1920s but has been majorly informed by research in the last decade 18,43 . The treatment options are percutaneous drainage, endoscopic cystenterostomy with or without necrosectomy, and video-assisted or open retroperitoneal debridement. ...
... The treatment options are percutaneous drainage, endoscopic cystenterostomy with or without necrosectomy, and video-assisted or open retroperitoneal debridement. The surgical mortality rate for these procedures is still between 10 and 20% despite improvements in fluid therapy and antibiotics 18,43 . The main conclusion of trials since the 1990s has hence been that sterile interstitial or necrotising pancreatitis should be managed conservatively, with invasive treatment reserved for patients in whom collections become infected or cause pain or other symptoms (e.g. ...
This report discusses the case of patient KT, who suffered from acute necrotising pancreatitis following endoscopic retrograde cholangiopancreatography (ERCP) for treatment of common bile duct (CBD) calculi. After a summary of KT’s complex medical history, the epidemiology and pathophysiology of post-ERCP pancreatitis (PEP) are discussed. Finally, recent research on treatment of severe necrotising pancreatitis is reviewed, focussing on strategies to reduce morbidity and mortality from this devastating complication of a common procedure like ERCP.
... The surgical odyssey in managing necrotizing pancreatitis is a notable example of how evidence-based knowledge leads to improvement in patient care. In the beginning of the 20th century surgeons such as Mayo Robson, Mickulicz, and Moynihan, in the context of the progression of anesthesia, were induced to deploy laparotomy in an effort to treat complications of severe AP [101]. Over the next decades surgical intervention became the therapy of choice despite a mortality rate greater than 50%. ...
Pancreatitis is a major public health issue worldwide. There is geographical variation in the burden of acute and chronic pancreatitis (CP). Globally, the age-standardized prevalence rate increased from 1990 to 2017. Acute pancreatitis (AP) is now one of the most common reasons for hospitalization with a gastrointestinal condition. The essential requirements for the management of AP are accurate diagnosis, appropriate triage, high-quality supportive care, monitoring for and treatment of complications, and prevention of relapse. Clinicians should be aware of the time course and the best management of AP, identifying which patient will have a severe course allowing earlier triage to an intensive care unit and earlier initiation of effective therapy. CP is a pathologic fibroinflammatory syndrome of the pancreas in individuals with genetic, environmental, and other risk factors who develop persistent pathologic responses to parenchymal injury or stress. Diagnosing the underlying pathologic process early in the disease course and managing the syndrome to change the natural course of disease and minimize adverse disease effects are the managing paradigm. In this review, we consider recent changes in the management of acute and CP, as well as common misunderstandings and areas of ongoing controversy.
... Acute pancreatitis (AP) is one of the main causes of acute abdomen and one of the most common gastrointestinal disorders requiring acute hospitalization and multidisciplinary management worldwide [1,2] with reported annual incidence of 10-80 cases per 100000 persons in different countries based on environmental features and lifestyle [2][3][4][5]. The disease may occur at any age, though it is rare in childhood [2,6]. ...
... AP has various aetiologies, most frequent biliary and alcoholic [1,5,[7][8][9], that lead to early activation of digestive enzymes inside acinar cells, with varying compromising of the gland itself, nearby tissues and other organs [2], the spectrum of the disease is wide and according to the recent revised Atlanta classification [10,11] there is a mild form (interstitial edematous pancreatitis) without organ failure, local or system complications, and usually self-limiting ( accounting for 80-85% of cases) , moderately severe AP (local complications without persistent organ failure), and severe AP that is associated with development of persistent organ failure. A fourth class of severity, critical AP, is described in the determinantbased classification [10,12] when both infected necrosis and persistent organ failure are present together. ...
Background: Acute pancreatitis (AP) is one of the main causes of acute abdomen that requires hospitalization and multidisciplinary management. The spectrum of the disease is wide with variable presentations that mimic the clinical features of other acute illnesses. Occasionally the diagnosis of AP is only made atlaparotomy, especially when there is doubt in the preoperative diagnosis. Objective: To evaluate the findings during exploratory laparotomy for patients with acute abdomen and were diagnosed as cases of AP intraoperatively, and to determine the postoperative outcome during the follow up period for these patients. Patients and Methods: A retospective study performed at the Department of General Surgery- Baquba Teaching Hospital- Diyala- Iraq, from January 2011 to December 2020. Thirty-three patients (16 male and 17 female) were included, all patients had history of acute abdomen with unknown cause preoperatively, in spite of doing the available preoperative investigations, and were found to have acute pancreatitis intraoperatively. A standardized data collection form was completed and analyzed for each patient. Results: The patients' ages ranged from 8 to 75 years with a mean age of 40.2 years. The majority of the patients were found to have pancreatic oedema (66.67%), followed by hemorrahgic pancreatitis (15.15%), pancreatic necrosis (12.12%) and pancreatic tumours that presented as acute pancreatitis (6.06%). During the follow up period 13 patients (39.39%) recovered with no complications while 20 patients (60.6%) developed one or more complication mainly surgical site infections in 18.18% of patients, pancreatic pseudocyst (15.15%), death (15.15%), ascites (9.1%), chronic pancreatitis (6.1%), pleural effusion (6.1%), while ileus, ARDS, DIC and acute renal failure occurred in (3%) for each. Conclusion: AP is an important cause of acute abdomen that is associated with severe mortality and morbidity and a high index of suspicion is needed to avoid the frequent misdiagnosis. Despite of rapid advances in the diagnostic strategy, still exploratory laparotomy is indicated in some cases to reach a sound diagnosis although such intervention is undesirable and might increase the postoperative morbidity and mortality. Keywords: acute abdomen, acute pancreatitis, explorative laparotomy, postoperative complications.
... /10.5772/intechopen.96747 beginning of the 20th century surgeons such as Mayo Robson, Mickulicz, and Moynihan, in the context of the progression of anesthesia, were induced to deploy laparotomy in an effort to treat complications of severe acute pancreatitis [31]. Over the next decades surgical intervention became the therapy of choice despite a mortality rate greater than 50%. ...
... The treatment of infected necrosis shifted to a more conservative approach also thanks to a comprehensive knowledge of the physio-pathological process of the systemic inflammatory response and the adoption of novel antibiotics in curbing systemic toxicity and protecting against organ failure. Recently, endoscopic debridement and minimally invasive techniques has been introduced [31,32]. ...
Acute pancreatitis has a broad clinical spectrum: from mild, self-limited disease to fulminant illness resulting in multi-organ failure leading to a prolonged clinical course with up to 30% mortality in case of infected necrosis. Management of local complications such as pseudocysts and walled-off necrosis may vary from clinical observation to interventional treatment procedures. Gram negative bacteria infection may develop in up to one-third of patients with pancreatic necrosis leading to a clinical deterioration with the onset of the systemic inflammatory response syndrome and organ failure. When feasible, an interventional treatment is indicated. Percutaneous or endoscopic drainage approach are the first choices. A combination of minimally invasive techniques (step-up approach) is possible in patients with large or multiple collections. Open surgical treatment has been revised both in the timing and in the operating modalities in the last decades. Since 1990s, the surgical treatment of infected necrosis shifted to a more conservative approach. Disruption of the main pancreatic duct is present in up to 50% of patients with pancreatic fluid collections. According to the location along the Wirsung, treatment may vary from percutaneous drainage, endoscopic retrograde pancreatography with sphincterectomy or stenting to traditional surgical procedures. Patients may suffer from vascular complications in up to 23% of cases. Tissue disruption provoked by lipolytic and proteolytic enzymes, iatrogenic complications during operative procedures, splenic vein thrombosis, and pseudoaneurysms are the pathophysiological determinants of bleeding. Interventional radiology is the first line treatment and when it fails or is not possible, an urgent surgical approach should be adopted. Chylous ascites, biliary strictures and duodenal stenosis are complications that, although uncommon and transient, may have different treatment modalities from non-operative, endoscopic to open surgery.
... The suddenness of its onset, the illimitable agony which accompanies it, and the mortality attendant upon it, all render it the most formidable of catastrophes. 1 Acute pancreatitis has been recognized since antiquity. An early description of AP was given by Ambrose pare in 1579. ...
Background: Acute pancreatitis is the most terrible of all the calamities that occur in connection with the abdominal viscera. The suddenness of its onset, the illimitable agony which accompanies it, and the mortality attendant upon it, all render it the most formidable of catastrophes. Aim of the study is to evaluate the treatment outcome in acute pancreatitis.Methods: All the patients who underwent surgery for chronic pancreatitis were included in the study. initial APACHE II score at admission and CT severity index was evaluated.Results: Edematous pancreatitis accounts for 80–90% of acute pancreatitis and remission can be achieved in most of the patients without receiving any special treatment. Necrotizing pancreatitis occupies 10–20% of acute pancreatitis and the mortality rate is reported to be 14-25%. Alcohol (45.8%) was the most common causes of acute severe pancreatitis in this study. Males were predominately affected (Male: Female = 29:5). Complication rate or morbidity is 50%. The initial APACHE II score at admission and CT severity index in the first scan were high in patients who underwent necrosectomy and the patients who died. The overall mortality in this study was 30.6%.Conclusions: In conclusion, one reason attributed to high mortality was due to the subgroup of patients who underwent PCD alone and failed to show any change in the recovery nor deterioration and lead to gross nutritional depletion and death, secondly those patients who underwent step up approach and ultimately needed surgery have more aggressive disease evidenced by high APACHE II score, CT severity index and % of necrosis.
... SAP is a complicated and dangerous condition with a high fatality rate. Past practices have shown that early surgery, debridement surgery and multiple surgeries can increase the incidence of postoperative complications (22). The International Association of Pancreatology (IAP) and the American Pancreatic Association (APA) recommend that the first best treatment for suspected or confirmed pancreatic necrosis should be PCD, and if necessary, followed by endoscopic or debridement operations on the necrotic tissue. ...
Background: Percutaneous catheter drainage (PCD) therapy is an important treatment for severe acute pancreatitis. Objectives: The purpose of this retrospective study was to analyze the relevant risk factors of computed tomography (CT) guided PCD during the treatment of infected pancreatic necrosis (IPN) in severe acute pancreatitis. Patients and Methods: This is a retrospective study. From January 2013 to November 2016, 162 patients suffering from severe acute pancreatitis with IPN were assessed using CT-guided PCD. Abdominal CT scan was performed for the patients. The interventional therapist chose the location and puncture according to the image. Depending on the efficacy and process of the treatment, these patients were divided into a PCD success treatment group and a PCD combined with surgery group. Factors affecting the success of PCD treatment were analyzed by logistic regression analysis. Results: Among the 162 cases, 71 cases (43.82%) were in the PCD success group and 91 cases (56.17%) were in the PCD combined with surgery group. Through the course of treatment, CT values of piercing zone, acute physiology and chronic health evaluation II (APACHEII) scores and modified CT severity index (MCTSI) scores showed statistically significant correlation with the therapeutic effect of PCD under CT guidance. A further multivariate analysis found that the CT value of puncture area is the best predictor for efficacy and when the CT value got higher the PCD efficacy would become lower. We performed further analysis of the factors associated with the average CT value in the puncture area which was higher than 20 Hounsfield unit (HU), and found that the length of time from patient admission to drainage, APACHEII scores, MCTSI scores and C reactive protein (CRP) levels were risk factors for PCD treatment efficacy. Conclusion: CT values of piercing zone is the major risk factor affecting the curative effect of CT guidance PCD. For patients with higher CT values in the puncture area, the longer time from patient admission to drainage, the higher APACHEII scores and MCTSI scores. Higher levels of C reactive protein seem to lower the curative effect.
... За даними В.С. Савельева рівень гематокриту більше 47% при госпіталізації та відсутність його зниження протягом 24 годин проведення інтенсивної терапії вказує на розвиток ПН [13,14]. Підвищення рівня глюкози від 8,0 до 15,0 ммоль/л є показником розвитку ПН та ПОН. ...
... In consideration of the long history of medical development and AP's widespread application, the best treatment has obviously improved. It was recognized that conservative treatment of INP was the major choice rather than surgery before the twentieth century (33). As the understanding of the disease deepens, surgical treatment (open necrosectomy) of severe pancreatitis gradually reached a consensus ten years ago. ...
... Previously, treatment of severe pancreatitis involved surgical treatment despite overwhelming mortality rates that often exceeded 50% (Bradley and Dexter, 2010;Werner et al., 2005). Recently, a significant paradigm shifts from surgical to early disease management involving analgesia, fluid resuscitation, antibiotics, nutrition, and endoscopic retrograde cholangiopancreatography yielding improved patient outcomes (Banks et al., 2010;Forsmark, 2013;Greenberg et al., 2016;McClave et al., 1998). ...
Background
Pancreatitis is an increasingly common clinical condition that causes significant morbidity and mortality. Cannabis use causes conflicting effects on pancreatitis development. We conducted a larger and more detailed assessment of the impact of cannabis use on pancreatitis.
Methods
We analyzed data from 2012 to 2014 of the Healthcare Cost and Utilization Project—Nationwide Inpatient Sample discharge records of patients 18 years and older. We used the International Classification of Disease, Ninth Edition codes, to identify 3 populations: those with gallstones (379,125); abusive alcohol drinkers (762,356); and non‐alcohol‐non‐gallstones users (15,255,464). Each study population was matched for cannabis use record by age, race, and gender, to records without cannabis use. The estimation of the adjusted odds ratio (aOR) of having acute and chronic pancreatitis (AP and CP) made use of conditional logistic models.
Results
Concomitant cannabis and abusive alcohol use were associated with reduced incidence of AP and CP (aOR: 0.50 [0.48 to 0.53] and 0.77 [0.71 to 0.84]). Strikingly, for individuals with gallstones, additional cannabis use did not impact the incidence of AP or CP. Among non‐alcohol‐non‐gallstones users, cannabis use was associated with increased incidence of CP, but not AP (1.28 [1.14 to 1.44] and 0.93 [0.86 to 1.01]).
Conclusions
Our findings suggest a reduced incidence of only alcohol‐associated pancreatitis with cannabis use.